AS
Alec Stranahan BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
40%
Neutral
40%
Negative
20%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $255 |
2%
downside
| 2 | +33% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $7 |
23%
upside
| 2 | -25% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Neutral
Downgraded
| $12 |
14%
downside
| 1 | – |
–
| 3 Sep ‘25 4 months ago |
|
|
|
Underperform
Downgraded
| $1 |
85%
downside
| 1 | -323% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Underperform
Downgraded
| $7 |
4%
downside
| 2 | +24% |
0
%
| 20 Aug ‘25 4 months ago |
|
|
|
Buy
Upgraded
| $42 |
52%
upside
| 1 | +24% |
0
%
| 28 Mar ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $12 | – | 1 | – |
–
| 5 Mar ‘25 10 months ago |
|